Uwe Langsenlehner

Graz, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

A multi-ancestry genome-wide study of tamoxifen metabolism and breast cancer recurrence.

A multi-ancestry genome-wide study of tamoxifen metabolism and breast cancer recurrence.

Journal: NPJ breast cancer

Published: December 03, 2025

Comprehensive geriatric assessment predicts radiation-induced acute toxicity in prostate cancer patients.

Comprehensive geriatric assessment predicts radiation-induced acute toxicity in prostate cancer patients.

Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Published: June 09, 2023

BCL2 genotypes and prostate cancer survival.

BCL2 genotypes and prostate cancer survival.

Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Published: October 24, 2016

The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.

The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: May 03, 2015

Vitamin D and prostate cancer prognosis: a Mendelian randomization study.

Vitamin D and prostate cancer prognosis: a Mendelian randomization study.

Journal: World journal of urology

Published: March 16, 2015

An elevated preoperative plasma fibrinogen level is associated with poor disease-specific and overall survival in breast cancer patients.

An elevated preoperative plasma fibrinogen level is associated with poor disease-specific and overall survival in breast cancer patients.

Journal: Breast (Edinburgh, Scotland)

Published: February 28, 2015

Evaluation of the platelet-to-lymphocyte ratio as a prognostic indicator in a European cohort of patients with prostate cancer treated with radiotherapy.

Evaluation of the platelet-to-lymphocyte ratio as a prognostic indicator in a European cohort of patients with prostate cancer treated with radiotherapy.

Journal: Urologic oncology

Published: November 23, 2014

Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients.

Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients.

Journal: World journal of urology

Published: October 07, 2014

Association of vascular endothelial growth factor--a gene polymorphisms and haplotypes with breast cancer metastases.

Association of vascular endothelial growth factor--a gene polymorphisms and haplotypes with breast cancer metastases.

Journal: Acta oncologica (Stockholm, Sweden)

Published: August 26, 2014

The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients.

The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients.

Journal: World journal of urology

Published: August 11, 2014

The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.

The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 30, 2014

The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients.

The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients.

Journal: British journal of cancer

Published: February 01, 2014

Showing 1-12 of 17

Last Updated: 09/26/2026